False-Positive Plasma Genotyping Due to Clonal Hematopoiesis
暂无分享,去创建一个
C. Paweletz | P. Jänne | Kwok-Kin Wong | P. Lizotte | Yuebi Hu | G. Oxnard | Y. Kuang | M. Awad | N. Feeney | N. Guibert | B. Ulrich | J. Supplee | Kwok-kin Wong
[1] K. Pienta,et al. Patient-Paired Sample Congruence Between 2 Commercial Liquid Biopsy Tests , 2017, JAMA oncology.
[2] Ash A. Alizadeh,et al. Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling. , 2017, Cancer Discovery.
[3] C. Paweletz,et al. Discrimination of Germline EGFR T790M Mutations in Plasma Cell-Free DNA Allows Study of Prevalence Across 31,414 Cancer Patients , 2017, Clinical Cancer Research.
[4] M. Ladanyi,et al. Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes. , 2017, Cell stem cell.
[5] Kari Stefansson,et al. Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly. , 2017, Blood.
[6] Bo Zhou,et al. Statistical analysis of mutant allele frequency level of circulating cell-free DNA and blood cells in healthy individuals , 2017, Scientific Reports.
[7] G. Lyman,et al. Comparison of 2 Commercially Available Next-Generation Sequencing Platforms in Oncology , 2017, JAMA oncology.
[8] J. Zehnder,et al. IDH2 Mutation in a Patient with Metastatic Colon Cancer. , 2017, The New England journal of medicine.
[9] James D. Brenton,et al. Liquid biopsies come of age: towards implementation of circulating tumour DNA , 2017, Nature Reviews Cancer.
[10] A. LaCasce,et al. Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] Marian Harris,et al. Institutional implementation of clinical tumor profiling on an unselected cancer population. , 2016, JCI insight.
[12] C. Paweletz,et al. Association Between Plasma Genotyping and Outcomes of Treatment With Osimertinib (AZD9291) in Advanced Non-Small-Cell Lung Cancer. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] Suzanne E Dahlberg,et al. Prospective Validation of Rapid Plasma Genotyping for the Detection of EGFR and KRAS Mutations in Advanced Lung Cancer. , 2016, JAMA oncology.
[14] B. Ebert,et al. Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes. , 2015, Blood.
[15] E. Zeggini,et al. Leukemia-Associated Somatic Mutations Drive Distinct Patterns of Age-Related Clonal Hemopoiesis , 2015, Cell reports.
[16] M. McCarthy,et al. Age-related clonal hematopoiesis associated with adverse outcomes. , 2014, The New England journal of medicine.
[17] S. Gabriel,et al. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. , 2014, The New England journal of medicine.
[18] Joshua F. McMichael,et al. Age-related cancer mutations associated with clonal hematopoietic expansion , 2014, Nature Medicine.
[19] C. Camargo,et al. Factors associated with positive D-dimer results in patients evaluated for pulmonary embolism. , 2010, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.
[20] S. Swensen,et al. Lung cancer screening with CT: Mayo Clinic experience. , 2003, Radiology.
[21] I. Tsigelny,et al. Genomic Landscape of Cell-Free DNA in Patients with Colorectal Cancer. , 2018, Cancer discovery.